Oxurion NV — Director's Dealing 2024

Sep 23, 2024

PRESS RELEASE

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM – September 24, 2024 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation¹ it has received a transparency notification as follows:

Oxurion received a transparency notification on September 23, 2024, from Atlas Special Opportunities, LLC indicating that as of September 23, 2024, it held 33,339 shares of the then outstanding 1,336,265 shares, and therefore crossed below the threshold (3%) by virtue of the sale of voting securities. See Annex 1.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forwardlooking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

For further information please contact:

________

Oxurion NV
Pascal Ghoson
Chief Executive Officer
Pascal.ghoson@oxurion.com

1. Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.

ANNEX 1

1) Status of the notification
	Fitzal
2) Issuer
Name Identification number	COURION 0881-820-924
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
	Downward crossing of the lowest threshold
4) Notification by
	A person that notifies alone
5) Persons subiect to the notification requirement.
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
	6) Rersons that disnose of voting nohts (only to be filed in it art. 7 of the Law applies)
	Name		Address (for legal entities)
1	Please continue entering the information in part & concerning the persons referred to in Sections 5 and 6		Part II
7) Date on which the threshold is crossed
		23/09/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
	ಗಾ
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
	1,338,286
	Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification		After the transaction
	# of voting rights		# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the seculities

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or Cate	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
TOTAL
	The totals will be updated once you have clicked on

TOTAL (A & B)		# of voting rights 1% of voting rights
	CALCULATE	33,339	2.49%

11) Full chain of controlled undertakings through which the holding is effectively held, it applicable

Allas Special Opportunities LLC is not a controlled entily.
12) In case of proxy voting for only one GM will cease to hald / voting rights as of Holder will hold again	PORTMENT THE T
13) Additional information
Ch 9 separiber 204 (with within in 1 September 220), 48th Special Copyriturities LC vide in Cruitor NY (as a real of elici its a number of the manning decreased b 12,413 harm 9.01%, denominator = 1,338,205). Cer 13 Separiter 2024 (with with the new in 17 Separation L.C 6/27, 20 shares in Cuccio N., in a real of Wich is shares in Chicities Marental in 19,03 shares in 19,03 shares
6.97%, denominator = 1,338,285). Chr 16 September 2024 (with with the Collection 2024). Alla Special Cycordunities L.C 6:01 A.6 (14) 11 shares in Church N.) as a reality which is which is which is which is w 5.87%, denominator = 1,336,285). Cor 17 Separiter 2024 (which in 19 September 2024). Alla Special Cycornities L.C (color N) (sa result of elice in children in Cruitor N) (serend by S.C. (series in Courten (s
denominator = 1,338,265). Chr 12 Separiter 2024 (which in 20 September 2024). Alla Special Cycolumbes LC 600 55,51 Starres in Church N. as a next of the Ranalerially decreend by 3,530 views (1 2.49%, denominator = 1,338,265).

644